Monday, September 21, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Trialssemaglutidesmoking cessationobesityuthealth houston

Texas team recruiting for semaglutide trial in smokers quitting cigarettes

The Phase 2 randomised trial tests once-weekly semaglutide 2.4 mg against post-cessation weight gain in adults with overweight or obesity.

PR
By Priya Raman · Science Reporter
Sep 21 08:00 ETSource: ClinicalTrials.gov

The wire

  1. 01NCT06173778, sponsored by UTHealth Houston and started 23 April 2024, is recruiting adult smokers with overweight or obesity for randomised once-weekly semaglutide 2.4 mg.
  2. 02Endpoints cover body weight, body composition and peripheral and central mechanisms of appetite, satiety and food intake during smoking cessation, a setting where weight gain often drives relapse.
  3. 03Phase 2 and still recruiting, so no results yet; investigator-sponsored design and unstated enrolment limit what can be inferred about effect size.

From the source

Semaglutide for Post-Smoking Cessation Weight Management

NCT06173778 · PHASE2 · RECRUITING · Sponsor: The University of Texas Health Science Center, Houston · Conditions: Obesity, Overweight, Cigarette Smoking.

Read at clinicaltrials.gov
Source URL https://clinicaltrials.gov/study/NCT06173778